By Alex Lawson ( May 1, 2014, 6:53 PM EDT) -- Avanir Pharmaceuticals Inc. prevailed in its patent infringement suit in Delaware federal court taking aim at bids from Par Pharmaceuticals Inc. and Impax Laboratories Inc. to market a generic version of Avanir's neurological disorder drug Nuedexta, the company announced Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.